source
- UniQure files FDA priority review request for Huntington’s gene therapy AMT-130UniQure, a Dutch biotech, announced on Wednesday that it has submitted applications to the U.S. Food and Drug Administration seeking a priority review for its gene therapy AMT-130, which targets th…
- Medline expands recall of reprocessed electrophysiology and ultrasound catheters due to contamination riskMedline Industries has issued an expanded recall that adds new lots of reprocessed electrophysiology and ultrasound catheters after the FDA identified possible residual particulates in the devices.…